Pharmaceutical

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- via IBN — Lucy Scientific Discovery Inc. (NASDAQ: LSDI) today announces its placement in…

9 months ago

Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

Niagara Falls, NY, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular…

9 months ago

Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference

WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to…

9 months ago

Rhythm Pharmaceuticals Announces Update to September Conference Participation

BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…

9 months ago

MMJ Positioned To Win DEA Lawsuit As HHS Verifies Marijuana Has Medical Benefit To Patients

Marijuana DeScheduling News Much To Do Over NothingWASHINGTON D.C. / ACCESSWIRE / September 8, 2023 / Attorney Megan Sheehan representing…

9 months ago

Theralase(R) Closes Private Placement Equity Financing

TORONTO, ON / ACCESSWIRE / September 7, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), is a clinical…

9 months ago

Satellos Bioscience Enters Into an Agreement with ICP Securities Inc. to Provide Market Making Services

Toronto, Ontario--(Newsfile Corp. - September 7, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a public…

9 months ago

Skye Bioscience Reverse Stock Split to Be Effective on September 8th

San Diego, California--(Newsfile Corp. - September 7, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing proprietary…

9 months ago

HumanFirst Launches New Enterprise Platform to Accelerate Adoption of Precision Measures and Artificial Intelligence in Clinical Research

HumanFirst's new solution aligns AI-powered biomarkers and clinical outcome assessments (COAs) across one platform to drive scientific progress, R&D efficiencies,…

9 months ago

Framework Solutions Expands its Suite of Services with the Strategic Acquisition of Govise, Inc. to Advance its Medical Review Capabilities

DANBURY, Conn. and SANTA ANA, Calif., Sept. 7, 2023 /PRNewswire/ -- Framework Solutions ("Frameworks"), a provider of clinical to commercial…

9 months ago